Skip to main content

Advertisement

Log in

South Asian Health: Inflammation, Infection, Exposure, and the Human Microbiome

  • Original Paper
  • Published:
Journal of Immigrant and Minority Health Aims and scope Submit manuscript

Abstract

This paper presents the results of the literature review conducted for the working group topic on inflammation, infection, exposure, and the human microbiome. Infection and chronic inflammation can elevate risk for cardiovascular disease and cancer. Environmental exposures common among South Asian (SA) subgroups, such as arsenic exposure among Bangladeshis and particulate matter air pollution among taxi drivers, also pose risks. This review explores the effects of exposure to arsenic and particulate matter, as well as other infections common among SAs, including human papillomavirus (HPV) and hepatitis B/C infection. Emerging research on the human microbiome, and the effect of microbiome changes on obesity and diabetes risk among SAs are also explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Smedley PL, Kinniburgh DG. A review of the source, behaviour and distribution of arsenic in natural waters. Appl Geochem. 2002;17(5):517–68.

    Article  CAS  Google Scholar 

  2. McCarty KM, Hanh HT, Kim KW. Arsenic geochemistry and human health in South East Asia. Rev Environ Health. 2011;26(1):71–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78(9):1093–103.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Dhar RK, Biswas BK, Samanta G, Mandal BK, Chakraborti D, Roy S, Jafar A, Islam A, Ara G, Kabir S, Quamruzzaman Q, Chakraborti D. Groundwater arsenic calamity in Bangladesh. Curr Sci. 1997;73(1):48–59.

    CAS  Google Scholar 

  5. Roychowdhury T. Impact of sedimentary arsenic through irrigated groundwater on soil, plant, crops and human continuum from Bengal delta: Special reference to raw and cooked rice. Food Chem Toxicol. 2008;46(8):2856–64.

    Article  CAS  PubMed  Google Scholar 

  6. Chen Y, Ahsan H. Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health. 2004;94(5):741–4.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Halder D, Bhowmick S, Biswas A, Mandal U, Nriagu J, Mazumdar DN, Chatterjee D, Bhattacharya P. Consumption of brown rice: a potential pathway for arsenic exposure in rural Bengal. Environ Sci Technol. 2012;46(7):4142–8.

    Article  CAS  PubMed  Google Scholar 

  8. Davis MA, Signes-Pastor AJ, Argos M, Slaughter F, Pendergrast C, Punshon T, Gossai A, Ahsan H, Karagas MR. Assessment of human dietary exposure to arsenic through rice. Sci Total Environ. 2017;586:1237–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. U.S. Food and Drug Administration: FDA releases preliminary data on arsenic levels in rice and rice products. 2012.

  10. Consumer Reports: Arsenic in your food: Our findings show a real need for federal standard for this toxin. November 2012 April 2014]; Available from: http://consumerreports.org/cro/magazine/2012/11/arsenic-in-your-food/index.htm.

  11. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich V, van Geen A, Graziano J, Ahsan H. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet. 2010;376(9737):252–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T, Ahmed A, Hasan R, Hasan K, Sarwar G, Levy D, Slavkovich V, Graziano JH, Rathouz PJ, Ahsan H. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol. 2011;174(2):185–94.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ruiz de Luzuriaga AM, Ahsan H, Shea CR. Arsenical keratoses in Bangladesh–update and prevention strategies. Dermatol Clin. 2011;29(1):45–51.

    Article  CAS  PubMed  Google Scholar 

  14. Guha Mazumder DN. Arsenic and non-malignant lung disease. J Environ Sci Health A. 2007;42(12):1859–67.

    Article  CAS  Google Scholar 

  15. Martinez VD, Vucic EA, Becker-Santos DD, Gil L, Lam WL. Arsenic exposure and the induction of human cancers. J Toxicol. 2011;2011:431287.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, Hsu LI, Chen CJ. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control. 2008;19(8):829–39.

    Article  PubMed  Google Scholar 

  17. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012;14(6):542–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Das N, Paul S, Chatterjee D, Banerjee N, Majumder NS, Sarma N, Sau TJ, Basu S, Banerjee S, Majumder P, Bandyopadhyay AK, States JC, Giri AK. Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health. 2012;12:639.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lewis DR, Southwick JW, Quellet-Hellstrom R, Rench J, Calderon RL. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect. 1999;107(5):359–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Benowitz NL. Cardiotoxicity in the workplace. Occup Med. 1992;7(3):465–78.

    CAS  PubMed  Google Scholar 

  21. Goldsmith S, From AH. Arsenic-induced atypical ventricular tachycardia. N Engl J Med. 1980;303(19):1096–8.

    Article  CAS  PubMed  Google Scholar 

  22. Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J. 2003;79(933):391–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pieters N, Plusquin M, Cox B, Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis. Heart. 2012;98(15):1127–35.

    Article  PubMed  PubMed Central  Google Scholar 

  24. United States Environmental Protection Agency: Particulate Matter. 2 April 2013 31 March 2014]; Available from: http://www.epa.gov/airscience/air-particulatematter.htm.

  25. Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–78.

    Article  CAS  PubMed  Google Scholar 

  26. Cavallari JM, Eisen EA, Chen JC, Fang SC, Dobson CB, Schwartz J, Christiani DC. Night heart rate variability and particulate exposures among boilermaker construction workers. Environ Health Persp. 2007;115(7):1046–51.

    Article  Google Scholar 

  27. Cavallari JM, Fang SC, Eisen EA, Schwartz J, Hauser R, Herrick RF, Christiani DC. Time course of heart rate variability decline following particulate matter exposures in an occupational cohort. Inhal Toxicol. 2008;20(4):415–22.

    Article  CAS  PubMed  Google Scholar 

  28. Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med. 2007;176(4):370–6.

    Article  CAS  PubMed  Google Scholar 

  29. Fang SC, Cassidy A, Christiani DC. A systematic review of occupational exposure to particulate matter and cardiovascular disease. Int J Env Res Public Health. 2010;7(4):1773–806.

    Article  CAS  Google Scholar 

  30. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation. 2001;104(9):986–91.

    Article  CAS  PubMed  Google Scholar 

  31. Wu S, Deng F, Niu J, Huang Q, Liu Y, Guo X. Association of heart rate variability in taxi drivers with marked changes in particulate air pollution in Beijing in 2008. Environ Health Perspect. 2010;118(1):87–91.

    Article  CAS  PubMed  Google Scholar 

  32. Wu SW, Deng FR, Niu J, Huang QS, Liu YC, Guo XB. The relationship between traffic-related air pollutants and cardiac autonomic function in a panel of healthy adults: a further analysis with existing data. Inhal Toxicol. 2011;23(5):289–303.

    Article  CAS  PubMed  Google Scholar 

  33. Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109(21):2655–71.

    Article  PubMed  Google Scholar 

  34. Min KB, Min JY, Cho SI, Paek D. The relationship between air pollutants and heart-rate variability among community residents in Korea. Inhal Toxicol. 2008;20(4):435–44.

    Article  CAS  PubMed  Google Scholar 

  35. Riediker M, Devlin RB, Griggs TR, Herbst MC, Bromberg PA, Williams RW, Cascio WE. Cardiovascular effects in patrol officers are associated with fine particulate matter from brake wear and engine emissions. Part Fibre Toxicol. 2004;1(1):2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Weichenthal S, Kulka R, Dubeau A, Martin C, Wang D, Dales R. Traffic-related air pollution and acute changes in heart rate variability and respiratory function in urban cyclists. Environ Health Perspect. 2011;119(10):1373–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Dockery DW, Pope CA, Xu XP, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An Association between Air-Pollution and Mortality in 6 United-States Cities. N England J Med. 1993;329(24):1753–9.

    Article  CAS  Google Scholar 

  38. Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer cardiopulmonary mortality and long-term exposure to fine particulate air pollution. J Am Med Assoc. 2002;287:1132–41.

    Article  CAS  Google Scholar 

  39. Pope CA 3rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995;151(3 Pt 1):669–74.

    Article  PubMed  Google Scholar 

  40. Gallus S, Negri E, Boffetta P, McLaughlin JK, Bosetti C, La Vecchia C. European studies on long-term exposure to ambient particulate matter and lung cancer. Eur J Cancer Prev. 2008;17(3):191–4.

    Article  PubMed  Google Scholar 

  41. Lepeule J, Laden F, Dockery D, Schwartz J. Chronic exposure to fine particles and mortality: an extended follow-up of the harvard six cities study from 1974 to 2009. Environ Health Perspect. 2012;120:965

    Article  PubMed  PubMed Central  Google Scholar 

  42. Turner MC, Krewski D, Pope CA 3rd, Chen Y, Gapstur SM, Thun MJ. Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med. 2011;184(12):1374–81.

    Article  PubMed  Google Scholar 

  43. Smith KR. National burden of disease in India from indoor air pollution. PNAS. 2000;97(24):13286–93.

    Article  CAS  PubMed  Google Scholar 

  44. Gany F, Bari S, Prasad L, Leng J, Lee T, Thurston G, Gordon T, Rexford B, Zelikoff J. Perception and reality of particulate matter (PM) exposure in New York City taxi drivers. Am J Public Health 2013;27:221. [In Preparation].

    Google Scholar 

  45. Schaller Consulting: The changing face of taxi and limousine drivers: U.S., large states and metro areas and New York City. Brooklyn: Schaller Consulting; 2004

    Google Scholar 

  46. Blasi G, Leavitt J. Driving poor: taxi drivers and the regulation of the taxi industry in Los Angeles. Los Angeles: UCLA Institute of Industrial Relations; 2006.

    Google Scholar 

  47. Waheed S, Romero-Alston L. UNFARE taxi drivers and the cost of moving the city. 2003.

  48. Gany FM, Gill PP, Ahmed A, Acharya S, Leng J. Every disease… man can get can start in this cab: focus groups to identify South Asian taxi drivers’ knowledge, attitudes and beliefs about cardiovascular disease and its risks. J Immigr Minor Health. 2013;15(5):986–92.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Apantaku-Onayemi F, Baldyga W, Amuwo S, Adefuye A, Mason T, Mitchell R, Blumenthal DS. Driving to better health: cancer and cardiovascular risk assessment among taxi cab operators in Chicago. J Health Care Poor Underserved. 2012;23(2):768–80.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Reiss K, Lehnhardt J, Razum O. Factors associated with smoking in immigrants from non-western to western countries—what role does acculturation play? A systematic review. Tob Induc Dis. 2015;13(1):11.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Hansen J, Raaschou-Nielsen O, Olsen JH. Increased risk of lung cancer among different types of professional drivers in Denmark. Occup Environ Med. 1998;55(2):115–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Jakobsson R, Gustavsson P, Lundberg I. Increased risk of lung cancer among male professional drivers in urban but not rural areas of Sweden. Occup Environ Med. 1997;54(3):189–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Guberan E, Usel M, Raymond L, Bolay J, Fioretta G, Puissant J. Increased Risk for lung-cancer and for cancer of the gastrointestinal-tract among geneva professional drivers. Brit J Ind Med. 1992;49(5):337–44.

    CAS  Google Scholar 

  54. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22(12):2675–86.

    Article  CAS  PubMed  Google Scholar 

  55. Munoz N, Bosch FX, Castellsague X, Diaz M, De Sanjose S, Hammouda D, Shah KV, Meijer C. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278–85.

    Article  CAS  PubMed  Google Scholar 

  56. cdc: hpv.

  57. Franceschi S, Bidoli E, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol. 2000;36(1):106–15.

    Article  CAS  PubMed  Google Scholar 

  58. Schwartz SM DJ, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90:1626–636

    Article  CAS  PubMed  Google Scholar 

  59. McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer. 2003;88(1):42–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen. 2009;16(4):193–8.

    Article  PubMed  Google Scholar 

  61. Cohen C, Caballero J, Martin M, Weerasinghe I, Ninde M, Block J. Eradication of hepatitis B: A nationwide community coalition approach to improving vaccination, screening, and linkage to care. J Commun Health. 2013;38:799–804

    Article  Google Scholar 

  62. Hu KQ, Pan CQ, Goodwin D. Barriers to screening for hepatitis B virus infection in Asian Americans. Dig Dis Sci. 2011;56(11):3163–71.

    Article  PubMed  Google Scholar 

  63. Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G. The prevalence of hepatitis B virus infection in the united states in the era of vaccination. J Infect Dis. 2010;202(2):192–201.

    Article  PubMed  Google Scholar 

  64. Adams KM, Gardiner LD, Assefi N. Healthcare challenges from the developing world: post-immigration refugee medicine. BMJ. 2004;328(7455):1548–52.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Hahne S, Ramsay M, Soldan K, Balogun K, Mortimer P. Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy. Arch Dis Child. 2003;88(12):1082–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Tong MJ, Pan CQ, Hann HW, Kowdley KV, Han SH, Min AD, Leduc TS. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56(11):3143–62.

    Article  CAS  PubMed  Google Scholar 

  67. Nguyen LH, Nguyen MH. Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther. 2013;37(10):921–36.

    Article  CAS  PubMed  Google Scholar 

  68. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55:S10-S15.

    Article  Google Scholar 

  69. Fabrizi F, Messa P, Martin P. Transmission of hepatitis C virus infection in hemodialysis: current concepts. Int J Artif Organs. 2008;31(12):1004–16.

    Article  CAS  PubMed  Google Scholar 

  70. Kosaraju K, Faujdar SS, Singh A, Prabhu R. Hepatitis viruses in heamodialysis patients: an added insult to injury?. Hepat Res Treat 2013; 2013:860514.

    PubMed  PubMed Central  Google Scholar 

  71. Bhattacharya S, Price N, Boxall E, Adu D, Lipkin G, Smith S, Osman H. Holiday haemodialysis and imported hepatitis C virus infection: A series of sixteen cases in two large haemodialysis units. J Clin Virol. 2009;45(4):296–9.

    Article  PubMed  Google Scholar 

  72. Jafferbhoy H, Miller MH, McIntyre P, Dillon JF. The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population. Epidemiol Infect. 2012;140(6):1048–53.

    Article  CAS  PubMed  Google Scholar 

  73. Perumalswami PV, Factor SH, Kapelusznik L, Friedman SL, Pan CQ, Chang C, Di Clemente F, Dieterich DT. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol. 2013;58(5):890–7.

    Article  PubMed  Google Scholar 

  74. Blaser MJ. Who are we? Indigenous microbes and the ecology of human disease. Eur Mol Biol Organ 2006;7(10): 956.

    CAS  Google Scholar 

  75. Croucher R, Dahiya M, Gowda KK. Contents and price of vendor assembled paan quid with tobacco in five London localities: a cross-sectional study. Tob Control. 2013;22(2):141–3.

    Article  PubMed  Google Scholar 

  76. Sommer F, Backhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–38.

    Article  CAS  PubMed  Google Scholar 

  77. Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887–94.

    Article  CAS  PubMed  Google Scholar 

  78. US Taxi and Limo Drivers Now Eligible for Group Health Benefits.

  79. Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol. 2013;34(3):1285–300.

    Article  PubMed  Google Scholar 

  80. Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian helicobacter pylori: facts or medical myths. J Dig Dis. 2009;10(2):77–84.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Khan AA, Shrivastava A, Khurshid M. Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochim Biophys Acta. 2012;1826(2):331–7.

    CAS  PubMed  Google Scholar 

  82. Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23(3):399–404.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A national heart, lung, and blood institute workshop report. Am J Respir Crit Care Med. 2013;187(12):1382–7.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Jobin C. Colorectal cancer: looking for answers in the microbiota. Cancer Discov. 2013;3(4):384–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE. 2012;7(6):e39743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, Delchier JC. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?. Therap Adv Gastroenterol 2013; 6(3).

  87. den Hollander WJ, Holster IL, den Hoed CM, van Deurzen F, van Vuuren AJ, Jaddoe VW, Hofman A, Perez-Perez GI, Blaser MJ, Moll HA, Kuipers EJ. Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city. J Gastroenterol Hepatol. 2013;28(11):1705–11.

    Article  Google Scholar 

  88. Perez-Perez GI, Olivares AZ, Foo FY, Foo S, Neusy AJ, Ng C, Holzman RS, Marmor M, Blaser MJ. Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J Urban Health. 2005;82(3):510–6.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence. Helicobacter. 2012;17(5):396–401.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002;97(5):1106–12.

    Article  PubMed  Google Scholar 

  91. Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, Scott KP, Buc Calderon P, Feron O, Muccioli GG, Sonveaux P, Cani PD, Delzenne NM. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer. 2012;107(8):1337–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Ou J, Carbonero F, Zoetendal EG, Delany JP, Wang M, Newton K, Gaskins HR, O’Keefe SJ. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013;98(1):111–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013;27(1):73–83.

    Article  CAS  PubMed  Google Scholar 

  94. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev. 2010;31(6):817–44.

    Article  CAS  PubMed  Google Scholar 

  95. Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhoolenzer F, Willeit J. Association ofendotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol. 1999;34:1975–81.

    Article  CAS  PubMed  Google Scholar 

  96. Miller M, McTernan PG, Harte AL, Silva NF, Strazzullo P, Alberti KG, Kumar S, Cappuccio. FP Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis. 2009;203(2):494–502.

    Article  CAS  PubMed  Google Scholar 

  97. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This publication was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number R13 MD007147- 01A1 and National Cancer Institute of the National Institutes of Health under Award Number P30 CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SAHI staff would like to thank the Steering Committee members, all working group co-chairs, the Memorial Sloan Kettering Cancer Center Library, Rohini Rau-Murthy and the SAHI interns for their assistance in assembling this document.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Gany.

Ethics declarations

Research Involving Human and Animal Rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Leng, J., Peruluswami, P., Bari, S. et al. South Asian Health: Inflammation, Infection, Exposure, and the Human Microbiome. J Immigrant Minority Health 21 (Suppl 1), 26–36 (2019). https://doi.org/10.1007/s10903-017-0652-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10903-017-0652-y

Keywords

Navigation